OrsoBio | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

15 results for “OrsoBio”

Trials

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

750 participants · First posted Apr 4, 2019

Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer

50 participants · First posted Mar 9, 2026

Evaluation of the Acceptability of a Multi-strain Probiotic Supplement (Smile Probio 45B) in Healthy Adults

40 participants · First posted Jan 23, 2026

Drugs

ACMSD inhibitor(OrsoBio)

Organizations

OrsoBio, Inc.

United States

Laboratorios Osorio de Moraes Ltda.

News

OrsoBio Secures $67M for Obesity Drugs, Vor Bio's AML Therapy Shows Promise, and More

OrsoBio's TLC-6740 Combination Therapy Achieves 51% Greater Weight Loss Than Tirzepatide Alone in Phase 1b/2a Trial

Novel Oral Drug TLC-2716 Reduces Triglycerides by 38% and Remnant Cholesterol by 61% in Phase 1 Trial

Page 1 of 2